This discovery, which has already been demonstrated to be safe and effective against several viral infections (hepatitis A, B, and C viruses, and SARS-CoV-2 virus), could change the way we treat viral infections. But we need funding to conduct clinical trials and bring this therapy to the world. Your support—whether as a patient, an advocate, or an investor—can help us validate this breakthrough and make rapid recovery a reality.

[Donate Now] 

Support the Future of Antiviral Therapy

A Paradigm Shift in Fighting Viruses

In a world still recovering from the devastating effects of COVID-19, it is clear that traditional antiviral approaches alone are not enough. Our groundbreaking research introduces a scalable, disruptive therapy—using harmless avian vaccine viruses to control infections. This paradigm-changing innovation could revolutionize how we combat viral diseases and prepare humanity for future pandemics.

Why Your Support Matters

Despite attracting significant scientific attention (31K views on our published paper), our calls for collaboration with universities and pharmaceutical companies have gone unanswered. As a small biotech company with limited resources, we rely on visionary supporters—patients, advocacy groups, and forward-thinking insurance companies—to help us accelerate this vital research.

How Your Contribution Helps

Your donation will directly support:

✅ Critical Research & Development – Advancing antiviral therapy and proving its efficacy.

✅ Rapid Prototyping & Clinical Trials – Ensuring accessibility and scalability of this life-saving technology.

✅ Global Pandemic Preparedness – Creating an antiviral solution that protects against future outbreaks.